Back

Nephrocare Health Services Ltd

IPO Details · GMP · Subscription · Financials

✅ Listed NSE & BSE Mainboard Live Chart
Issue Price
₹460
Per Share
GMP
+₹15
+3.26% Grey Market
Est. Listing
₹475
Expected Price
Min. Application
₹29,440
2 lots × 32 shares
IPO Issue Details
Issue Price / Price Band₹460 per share (Fixed Price)
Face Value₹2 Per Share
Lot Size32 Shares per Lot
Total Issue Size1,89,35,819 shares (aggregating up to ₹871.05 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenWed, 10 Dec 2025
Subscription CloseFri, 12 Dec 2025
Anchor AllotmentTue, 09 Dec 2025
Basis of AllotmentMon, 15 Dec 2025
Initiation of RefundsTue, 16 Dec 2025
Credit of Shares to DematTue, 16 Dec 2025
Listing DateWed, 17 Dec 2025
UPI Mandate Deadline2025-12-12
Application & Investment Details
Retail — Min (1 Lots)₹14,720 — 32 shares
Retail — Max (13 Lots)₹191,360 (13 Lots)
HNI — Min (68 Lots)₹10,00,960 — 2,176 shares
EPS (Pre-IPO)₹7.24
EPS (Post-IPO)₹2.84
P/E Ratio (Pre-IPO)63.52x
P/E Ratio (Post-IPO)162.19x
Pre-IPO Promoter Holding9,26,50,799 shares
Post-IPO Promoter Holding10,03,33,516 shares
Fresh Issue Shares76,82,717 shares (aggregating up to ₹353.40 Cr)
Offer for Sale Shares1,12,53,102 shares of ₹2 (aggregating up to ₹517.64 Cr)
About Nephrocare Health Services Ltd

Incorporated in 2010, Nephrocare Health Services Ltd. provides end-to-end dialysis care through a wide network of clinics across India and select international markets. The company offers services including diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy.As of Sep 30, 2025, Nephrocare operated 519 clinics with 51 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 288 cities in 21 States and 4 Union Territories. Approximately 77.53% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions.During Fiscal 2025, Nephrocare served 29,281 patients and completed 2,885,450 dialysis treatments, accounting for roughly 10% of the country's total dialysis patient base. Additionally, by Sep 30, it has served 31,046 patients and completed 1,591,377 treatments in India. As of Sep 30, 2025, the company has 5,562 dialysis machines.Nephrocare has formed strategic partnerships with established hospital chains such as Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers.Competitive strengthsIndia’s and Asia’s largest dialysis chain with leadership across our marketsScale coupled with asset-light model driving cost efficiencies and operational excellenceDriving clinical excellence and quality through protocols and advanced technologyOrganic growth augmented by proven track record of acquisitions and integration in India and internationallyPatient-centric leadership and seasoned management team backed by marquee investorsDriving sustainable dialysis leadership with environmental, social and governance measuresTrack record of sustainable growth, profitability and return

Objects of the Issue

Nephrocare Health Services Ltd proposes to utilise the net proceeds from the Issue for the following objects:

1
Capital expenditure by the Company for opening new dialysis clinics in India
129.11
2
Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company
136.00
3
General corporate purposes
Shareholding & Lock-in
Pre-IPO Promoter Holding 9,26,50,799 shares
Post-IPO Promoter Holding 10,03,33,516 shares
Check AllotmentCheck Status →
Nephrocare Health Services Ltd — Live Price LIVE
₹460.00
INR · BSE
Fetching live data…
VS Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading chart…
Chart Not Available
Nephrocare Health Services Ltd is not yet listed on Yahoo Finance or has a different ticker symbol.
Try again after listing stabilises (2-3 trading days).
Issue ₹460.00 GMP: +₹15 (+3.26%) Live Price
Quick Facts
GMP Signal🟢 Positive
StatusListed
Issue Price₹460
GMP+₹15
Est. Listing₹475
Lot Size32 shares
Min Amount₹29,440
Listing Date17 Dec 2025
Disclaimer: GMP is unofficial and unregulated. It does not guarantee actual listing price.
Listing Performance
Issue Price₹460
Listing Date17 Dec 2025
Listing Price
Listing Gain/Loss—%
52-Week High
52-Week Low
Issue Structure & Reservation
Category Shares Offered % Issue Amount (₹ Cr)* Subscription
TOTAL 18,935,819 100.00% ₹871.05 Cr
* Based on ₹460.00 (upper price band)
Lot Size & Investment Details
Lot Size
32
Shares
Issue Price
₹460.00
Per Share
Min Investment
₹14,720
1 Lot
Category Lots Shares Amount (₹)
Retail (Min) 1 32 ₹14,720
Retail (Max) 13 416 ₹191,360
sNII (Min) 14 448 ₹206,080
bNII (Min) 68 2,176 ₹1,000,960
Company Financials — Restated Consolidated (Amount in ₹ Crore)
Particulars30 Sep 202531 Mar 202531 Mar 2024
Revenue from Operations 483.97 769.92 574.72
EBITDA 110.31 166.64 99.66
Profit After Tax (PAT) 14.23 67.10 35.13
Net Worth 716.06 594.21 423.55
Total Assets 1193.68 996.46 806.02
Reserves & Surplus 704.14 578.68 408.57
Total Borrowings 207.04 225.80 243.37
Key Ratios & Valuation
Issue Price ₹460
Face Value ₹2 Per Share
P/BV 7.72
RoE 13.45%
RoCE 18.67%
RoNW 13.19%
PAT Margin (%) 8.88%
EBITDA Margin (%) 22.05%
Debt / Equity N/A
Company Details
Company
Nephrocare Health Services Ltd
Exchange
NSE & BSE
IPO Type
Mainboard IPO
Issue Type
Bookbuilding IPO
Face Value
₹2 Per Share
Script Code
N/A
Address
5 th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad, Telangana, 500081
Book Running Lead Managers
ICICI Securities Ltd
Book Running Lead Manager (BRLM)
Ambit Pvt.Ltd
Book Running Lead Manager (BRLM)
IIFL Capital Services Ltd
Book Running Lead Manager (BRLM)
Nomura Financial Advisory & Securities (India) Pvt.Ltd
Book Running Lead Manager (BRLM)